BioAge Labs, Inc. (BIOA) AI Dilution Summary

BioAge reported cash of $318,745,000 at 2026-06-30 against estimated monthly burn of $6,420,000. Its funding channel is an ATM program with Leerink Partners LLC authorised to $75,000,000. Under it, 2,400,000 shares ($33,900,000) were sold from the start of the program through 2026-06-30, and sales after 2026-06-30 are not yet reported.